Fate of individuals with ischemic amputations in the REACH Registry: Three-year cardiovascular and limb-related outcomes

Atherosclerosis

Volumn 221, Issue 2, 2012, Pages 527-535

  Abola, Maria Teresa B ^a   Bhatt, Deepak L ^b   Duval, Sue ^c   Cacoub, Patrice P ^e   Baumgartner, Iris ^d   Keo, Hong ^k   Creager, Mark A ^f   Brennan, Danielle M ^g   Steg, Ph Gabriel ^h,i,j   Hirsch, Alan T ^c  

^a PHILIPPINE HEART CENTER   (Philippines)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d Kantonsspital Frauenfeld   (Switzerland)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h INSERM   (France)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

^j BICHAT HOSPITAL   (France)

^k CANTONAL HOSPITAL AARAU   (Switzerland)

more..

Author keywords

Amputation; Atherosclerosis; Critical limb ischemia; Health outcomes; Myocardial infarction; Peripheral artery disease

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BIGUANIDE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; AMPUTATION; ANGIOPLASTY; ANTIHYPERTENSIVE THERAPY; ARTICLE; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITALIZATION; HUMAN; LEG AMPUTATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RISK REDUCTION; STROKE;

AGED; AMPUTATION; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITALIZATION; HUMANS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LOWER EXTREMITY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84858704479     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.01.002     Document Type: Article

References (41)

1. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA 2005 Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery. Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006, 47(6):1239-1312.
2. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007, (Suppl. 45S):S5-S67. TASC II Working Group.
3. Regenbogen S.E., Gawande A.A., Lipsitz S.R., Greenberg C.C., Jha A.K. Do differences in hospital and surgeon quality explain racial disparities in lower extremity vascular amputations?. Ann Surg 2009, 250(3):424-431.
4. Most R.S., Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983, 6(1):87-91.
5. Feinglass J., Pearce W.H., Martin G.J., et al. Postoperative and late survival outcomes after major amputation: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program. Surgery 2001, 130(1):21-29.
6. Uniwin N. Epidemiology of lower extremity amputation in centers in Europe. North America and East Asia. The global lower extremity amputation study group. Br J Surg 2000, 87:328-337.
7. Aquino R., Johnnides C., Makaroun M., et al. Natural history of claudication: long-term serial follow-up study of 1244 claudicants. J Vasc Surg 2001, 36(6):962-970.
8. Engelhardt M., Boos J., Bruijnen H., et al. Critical limb ischaemia: initial treatment and predictors of amputation-free survival. Eur J Vasc Endovasc Surg 2012, 43(1):55-61. [Epub 2011 Oct 15].
9. Dormandy J., Heeck L., Vig S. Major amputations: clinical patterns and predictors. Semin Vasc Surg 1999, 12(2):154-161.
10. Benoit E., O'Donnell T., Iafrati M., et al. The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design. J Transl Med 2011, 9:165.
11. Powell R.J., Comerota A.J., Berceli S.A., et al. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia. J Vasc Surg 2011, 54(4):1032-1041.
12. Belch J., Hiatt W.R., Baumgartner I., et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 2011, 377(9781):1929-1937.
13. Kannel W.B., Manning F.M. Natural history of angina pectoris in the Framingham study: prognosis and survival. Am J Cardiol 1972, 29(2):154-163.
14. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119(3):e21-e181.
15. Lewandowski C.A., Rao C.P., Silver B. Transient ischemic attack: definitions and clinical presentations. Ann Emerg Med 2008, 52(2):S7-S16.
16. Reiber G.E., Pecoraro R.E., Koepsell T.D. Risk factors for amputation in patients with diabetes mellitus. A case-control study. Ann Intern Med 1992, 117(2):97-105.
17. Nash T., Bellew J.W., Cunningham M., McCulloch J. Identifying cause for advancement to amputation in patients with diabetes: the role of medical care and patient compliance. Wounds 2005, 17(2):32-36. Available at: http://www.woundsresearch.com/article/3756.
18. Faglia E., Clerici G., Clerissi J., et al. Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care 2009, 32(5):822-827. [erratum in: Diabetes Care 2009;32(7):1355].
19. Varu V.N., Hogg M.E., Kibbe M.R. Critical limb ischemia. J Vasc Surg 2010, 51(1):230-241.
20. Caro J., Migliaccio-Walle K., Ishak K.J., Proskorovsky I. The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord 2005, 5:14.
21. Dick F., Diehm N., Galimanis A., et al. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg 2007, 45(4):751-761.
22. Bhatt D.L., Steg P.G., Ohman E.M., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006, 295(2):180-189. REACH Registry Investigators.
23. Steg P.G., Bhatt D.L., Wilson P.W., et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007, 297(11):1197-1206. REACH Registry Investigators.
24. Mayfield J., Reiber G.E., Maynard C., et al. Survival following lower-limb amputation in a veteran population. J Rehabil Res Dev 2001, 38(3):341-345.
25. Hirsch A.T., Hartman L., Town R.J., Virnig B.A. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med 2008, 13(3):209-215.
26. Mahoney E.M., Wang K., Cohen D.J., et al. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes 2008, 1(1):38-45. REACH Registry Investigators.
27. Peacock J.M., Keo H.H., Duval S., et al. The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008. Prev Chronic Dis 2011, 8(6):A141.
28. Tan M.L.M., Feng J., Gordois A., Wong E.S.D. Lower extremity amputation prevention in Singapore: economic analysis of results. Singapore Med J 2011, 52(9):662-668.
29. De Frang R.D., Taylor L.M., Porter J.M. Basic data related to amputations. Ann Vasc Surg 1991, 5(2):202-207.
30. Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia. The Global Lower Extremity Amputation Study Group. Br J Surg 2000, 87(3):328-337. Global Lower Extremity Amputation Study Group.
31. Cacoub P.P., Abola M.T., Baumgartner I., et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 2009, 204(2):e86-e92. REACH Registry Investigators.
32. Tentolouris N., Al-Sabbagh S., Walker M., Boulton A.J., Jude E.B. Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up study. Diabetes Care 2004, 27(7):1598-1604.
33. Cruz C.P., Eidt J.F., Capps C., Kirtley L., Moursi M.M. Major lower extremity amputations at a Veterans Affairs hospital. Am J Surg 2003, 186(5):449-454.
34. Aulivola B., Hile C.N., Hamdan A., et al. Major lower extremity amputation: outcome of a modern series. Arch Surg 2004, 139(4):395-399.
35. Taylor S., Kalbaugh C.A., Blackhurst D.W., et al. Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: an analysis of 553 consecutive patients. J Vasc Surg 2005, 42(2):227-235.
36. Trautner C., Haastert B., Spraul M., Giani G., Berger M. Unchanged incidence of lower-limb amputations in a German city, 1990-1998. Diabetes Care 2001, 24(5):855-859.
37. Izumi Y., Satterfield K., Lee S., Harkless L.B., Lavery L.A. Mortality of first-time amputees in diabetics: a 10-year observation. Diabetes Res Clin Pract 2009, 83(1):126-131.
38. Sandnes D.K., Sobel M., Flum D.R. Survival after lower extremity amputation. J Am Coll Surg 2004, 199(3):394-402.
39. Faglia E., Favales F., Morabito A. New ulceration, new major amputation, and survival rates in Diabetic Subject Hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up. Diabetes Care 2001, 24(1):78-83.
40. Calle-Pascual A., Dura'n A., Diaz A., et al. Comparison of peripheral arterial construction in diabetic and non-diabetic patients: a prospective clinic-based study. Diab Res Clin Pract 2001, 53(2):129-136.
41. Brown L., Johnson J., Majumdar S., Tsuyuki R., McAlister F. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. Canad Med Assoc J 2004, 171(10):1189-1192.